alanine and Dihydrotanshinone I

alanine has been researched along with Dihydrotanshinone I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Armstrong, LA; Beale, R; Bineva-Todd, G; Canal, B; Diffley, JFX; Drury, LS; Howell, M; Kulathu, Y; Labib, K; Lim, CT; Milligan, JC; O'Reilly, N; Ozono, E; Tan, KW; Ulferts, R; Weissmann, F; Wu, M; Zeisner, TU; Zeng, J	1

Other Studies

1 other study(ies) available for alanine and Dihydrotanshinone I

Article	Year
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease. The Biochemical journal, 2021, 07-16, Volume: 478, Issue:13 Topics: Adenosine Monophosphate; Alanine; Aniline Compounds; Animals; Antiviral Agents; Benzamides; Chlorocebus aethiops; Coronavirus Papain-Like Proteases; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Assays; Flavins; Fluorescence Resonance Energy Transfer; Furans; High-Throughput Screening Assays; Inhibitory Concentration 50; Naphthalenes; Phenanthrenes; Quinones; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Vero Cells; Virus Replication	2021

Article

Year

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease.

The Biochemical journal, 2021, 07-16, Volume: 478, Issue:13

Topics: Adenosine Monophosphate; Alanine; Aniline Compounds; Animals; Antiviral Agents; Benzamides; Chlorocebus aethiops; Coronavirus Papain-Like Proteases; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Assays; Flavins; Fluorescence Resonance Energy Transfer; Furans; High-Throughput Screening Assays; Inhibitory Concentration 50; Naphthalenes; Phenanthrenes; Quinones; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Vero Cells; Virus Replication

2021